FindTrial
Sign In

VOY-101

BIOLOGICAL3 trials

Sponsors

Perceive Biotherapeutics, Inc.

Conditions

Age-Related Macular DegenerationAge-Related Macular Degeneration (AMD)Age-related Macular DegenerationGeographic AtrophyNon-Neovascular Age-Related Macular DegenerationNon-neovascular AMDNon-neovascular Age-related Macular Degeneration

Phase 1

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
Active, not recruitingNCT05380492
Perceive Biotherapeutics, Inc.Age-related Macular Degeneration, Geographic Atrophy
Start: 2022-11-17End: 2025-11-30Target: 45Updated: 2024-04-11
Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
Active, not recruitingNCT06087458
Perceive Biotherapeutics, Inc.Age-Related Macular Degeneration, Geographic Atrophy, Non-neovascular Age-related Macular Degeneration +1
Start: 2023-06-21End: 2028-06-01Target: 60Updated: 2026-08-17

Unknown Phase

Long-Term Follow Up of VOY-101 Non-nAMD Extension Study
Enrolling by invitationNCT07660640
Perceive Biotherapeutics, Inc.Age-Related Macular Degeneration (AMD), Non-Neovascular Age-Related Macular Degeneration
Start: 2026-03-03End: 2031-08-30Target: 88Updated: 2026-06-22